Michel Rives

754 citations
17 papers · 244 indexed · h-index 11
Topics
Head and Neck Cancer Studies (9 papers)Advanced Radiotherapy Techniques (7 papers)Salivary Gland Tumors Diagnosis and Treatment (5 papers)
Partner nations
FranceSwitzerlandEgypt

In The Last Decade

Michel Rives

17 papers receiving 242 citations

Peers

Michel Rives
Comparison fields: 5 of 39
  • Surgery 108
  • Oncology 107
  • Otorhinolaryngology 91
  • Pulmonary and Respiratory Medicine 68
  • Radiation 59
Replace Matteo Augugliaro with:
Matteo Augugliaro Italy
J. Mengual Spain
Jacek Skoczylas Poland
E. Fernández-Velilla Spain
A. Millà Spain
Madhup Rastogi India
Mina Yu South Korea
Rodger M. Pryzant United States
Niels Gyldenkerne Denmark
Giuseppe Giovinazzo Italy
Michel Rives relative to Matteo Augugliaro Italy Matteo Augugliaro's profile →
Citations per field
00.5×10×12.5×
Matteo Augugliaro · 1×
Citations per year

Countries citing papers authored by Michel Rives

Since Specialization
Citations

This map shows the geographic impact of Michel Rives's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michel Rives with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michel Rives more than expected).

Fields of papers citing papers by Michel Rives

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michel Rives. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michel Rives. The network helps show where Michel Rives may publish in the future.

Co-authorship network of co-authors of Michel Rives

This figure shows the co-authorship network connecting the top 25 collaborators of Michel Rives. A scholar is included among the top collaborators of Michel Rives based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michel Rives. Michel Rives is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
#WorkIndexed citations
1 4
2 10
3 42
4 20
5 10
6 12
7 6
8 11
9 8
10 6
11 15
12 5
13 32
14 13
15 27
16 20
17 3

About Michel Rives

Michel Rives is a scholar working on Otorhinolaryngology, Radiation and Surgery, having authored 17 papers that have together received 244 indexed citations. Recurring topics across this work include Head and Neck Cancer Studies (9 papers), Advanced Radiotherapy Techniques (7 papers) and Salivary Gland Tumors Diagnosis and Treatment (5 papers). The work is most often cited by research in Otorhinolaryngology (91 citations), Radiation (59 citations) and Oncology (107 citations). Michel Rives has collaborated with scholars based in France, Switzerland and Egypt. Frequent co-authors include Thomas Filleron, S. Vergèz, Anne Laprie, Jacques Bonnet, M. Delannes, M. Alfonsi, A. Modesto, P. Gräff, L. Vieillevigne and Yungan Tao. Their work appears in journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics and The Journal of Pediatrics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026